HELXvsFBTETF Comparison
Franklin Genomic Advancements ETF (HELX) belongs to the BioTech & Genomics segment. First Trust NYSE Arca Biotechnology Index Fund ETF (FBT) is part of the US Health Care segment. HELX's top 3 sector exposures are Health Care, Materials and Information Technology. In contrast, FBT's top sector exposures are Health Care, HELX is less expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.54% for FBT. HELX is down -1.22% year-to-date (YTD) with +$2M in YTD flows. FBT performs better with 9.61% YTD performance, and +$1.12B in YTD flows. Run a side-by-side ETF comparison of HELX and FBT below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
HELX vs FBT performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | HELX FBT | +9.44%+6.07% | +10.46%+16.55% | -1.22%+9.61% | +30.57%+36.78% | +14.77%+43.52% | -22.60%+29.85% |
| Flows | HELX FBT | --$487K | -+$23M | +$2M+$1.12B | +$8M+$1.17B | +$9M+$677M | +$14M+$374M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | HELX FBT | +26.51%+24.18% | +21.11%+21.22% | +20.62%+20.51% | +23.64%+22.00% |
| Max drawdown | HELX FBT | -6.54%-4.45% | -17.89%-14.27% | -29.16%-19.92% | -58.50%-29.91% |
| Max drawdown duration | HELX FBT | 38d16d | 197d126d | 458d237d | 1742d1159d |
HELX | FBT | |
Last sale 6/15/2026 at 2:14 PM | $35.82 | $226.43 |
| Previous close 06/15/2026 | $35.45 | $227.70 |
| Consolidated volume 06/15/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
HELX | FBT | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
HELX | FBT | |
|---|---|---|
| Last price | $35.82 | $226.43 |
| 1D performance | +1.03% | -0.56% |
| AuM | $23.30 M | $2.61 B |
| E/R | 0.5% | 0.54% |
HELX | FBT | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Franklin Templeton | First Trust |
| Benchmark | - | NYSE Arca Biotechnology Index |
| N° of holdings | 50 | 28 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | February 25, 2020 | June 19, 2006 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
